1. Home
  2. PHAR vs EVLV Comparison

PHAR vs EVLV Comparison

Compare PHAR & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • EVLV
  • Stock Information
  • Founded
  • PHAR 1988
  • EVLV 2013
  • Country
  • PHAR Netherlands
  • EVLV United States
  • Employees
  • PHAR N/A
  • EVLV N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • EVLV Computer peripheral equipment
  • Sector
  • PHAR Health Care
  • EVLV Technology
  • Exchange
  • PHAR Nasdaq
  • EVLV Nasdaq
  • Market Cap
  • PHAR 627.5M
  • EVLV 590.8M
  • IPO Year
  • PHAR N/A
  • EVLV N/A
  • Fundamental
  • Price
  • PHAR $9.98
  • EVLV $3.19
  • Analyst Decision
  • PHAR Strong Buy
  • EVLV Strong Buy
  • Analyst Count
  • PHAR 3
  • EVLV 5
  • Target Price
  • PHAR $27.00
  • EVLV $5.60
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • EVLV 1.5M
  • Earning Date
  • PHAR 03-13-2025
  • EVLV 02-27-2025
  • Dividend Yield
  • PHAR N/A
  • EVLV N/A
  • EPS Growth
  • PHAR N/A
  • EVLV N/A
  • EPS
  • PHAR N/A
  • EVLV N/A
  • Revenue
  • PHAR $285,745,000.00
  • EVLV $89,220,000.00
  • Revenue This Year
  • PHAR $20.08
  • EVLV $28.84
  • Revenue Next Year
  • PHAR $9.22
  • EVLV $30.41
  • P/E Ratio
  • PHAR N/A
  • EVLV N/A
  • Revenue Growth
  • PHAR 30.64
  • EVLV 17.67
  • 52 Week Low
  • PHAR $6.65
  • EVLV $2.01
  • 52 Week High
  • PHAR $13.20
  • EVLV $5.73
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.13
  • EVLV 39.04
  • Support Level
  • PHAR $9.37
  • EVLV $3.07
  • Resistance Level
  • PHAR $10.15
  • EVLV $3.35
  • Average True Range (ATR)
  • PHAR 0.50
  • EVLV 0.22
  • MACD
  • PHAR -0.09
  • EVLV -0.08
  • Stochastic Oscillator
  • PHAR 57.53
  • EVLV 17.07

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and advanced sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: